Salah (Sal) Dagher

At AstraZeneca, we are dedicated to improving patient outcomes for lung cancer by emphasizing early detection. By identifying the disease at its earliest stages, we can implement timely and effective treatments, ultimately enhancing patient quality of life and reducing the long-term burden on healthcare systems. Our commitment to innovative research and advanced diagnostic technologies underscores our mission to transform the future of healthcare. Additionally, in #NearEast and #Maghreb we are actively involved in initiatives such as lung cancer screening via government and patient association collaborations to promote equitable access to cancer care. More into this subject and preventive measures can be found in this article by Independent Arabia https://lnkd.in/ekaXscKe #WorldLungCancerDay #LungCancer #EarlyDetection Peter Raouf Sarah Sakr Khoury Jennifer Jackson George Fouad Jinane Hajjar Amine Sekhri Ayman Rahhal Mohanad Alyas Abdulkareem Al Dissi Maria Nauss

78

Hikma Pharmaceuticals PLC and its subsidiaries (‘Hikma’ or ‘Group’), the multinational pharmaceutical company, today reports its interim results for the six months ended 30 June 2024. The Group reported revenue growth of 10% (10% in constant currency) to $1.569 billion (compared to $1.427 billion in H1 2023). Riad Mishlawi, Chief Executive Officer of Hikma, said: “We had an excellent first half of the year. All of our businesses contributed to our strong performance, delivering 10% Group revenue growth. We launched new products across all regions, entered new markets in Europe, and further strengthened our leadership team. Our Branded business performed extremely well, benefitting from the ongoing investment in growing our portfolio of oncology and chronic treatments. Injectables is maintaining good momentum, with new launches and recently added capacity driving growth, while our strategic acquisition of Xellia’s products, manufacturing facility and R&D assets, once closed, will support the long-term prospects of this business. Generics continues to differentiate through our focus on more complex products and the quality of our US-based manufacturing capabilities. The outlook for 2024 remains strong and we are pleased to upgrade Group revenue and profit guidance.” #Hikma #Results #Growth #RandD 👉 https://lnkd.in/eqpqn4xV For more information, please visit: www.hikma.com

8

1 Comment

Evofem Biosciences is expanding in the #MiddleEast through a licensing and supply agreement with Pharma 1 Drug Store L.L.C, a leading #Emirati healthcare provider. This partnership brings #Phexxi®, an #innovative #hormonefree #contraceptive, to women in the #UAE, #Kuwait, #SaudiArabia, and #Qatar. Pharma 1 drug store L.L.C will manage regulatory approvals, distribution, sales, and marketing efforts, ensuring Phexxi®'s success in these key markets. This collaboration aligns with Evofem's strategic goals of global expansion and revenue diversification, while meeting the growing demand for on-demand, hormone-free contraception. #EvofemBiosciences #Pharma1DrugStore #WomensHealth #ReproductiveHealth #GCC #MENA #StrategicPartnership #MarketExpansion #Innovation #RASLifeScienceSolutions

1

Our full-slide summary of the Gordon et al. study “Bimekizumab safety in patients with moderate-to-severe plaque psoriasis: pooled data from up to 3 years of treatment in randomized phase III trials” is now live on the #IMIDforum ! The Immune-Mediated Inflammatory Disease Forum is a valuable resource for keeping you up to date with hand-selected dermatology publications. Visit the website to view this content and more #PsO #Bimekizumab #Safety https://ow.ly/osVz50RAfrp

2

Hope for those battling Huntington's disease (HD) in the MENA region! IROS CRO, Prilenia, and the #InternationalHuntingtonDiseaseAssociation are launching the first-ever #clinicaltrial for HD in the region. This trial aims to raise #awareness, provide #access to #treatment, and gather crucial #data. Huntington's disease is a #rare, progressive #neurodegenerativedisorder causing #abnormalmovements, #psychiatric issues, and #cognitive decline. This trial brings hope to patients with a new treatment, #pridopidine. Let's spread the word and support this groundbreaking collaboration! #HuntingtonsDisease #MENAHealthcare #PharmaceuticalInnovation #Prilenia #MENA

2

I was prevailed to receive an invitation to join a podcast tomorrow (Friday 6 Dec, 2024) as an expert with Dr. Abdelrahman Baz in Repsology LIVE podcast🎙. we will talk about the impact of AI and digital revolution on the future of pharmaceutical promotion. Tune in tomorrow at 8:00 PM GMT (10:00 PM Cairo time)! 🎙️👨‍⚕️💊 #AI #Podcast #Pharmaceuticals #Technology #Future #DigitalRevolution #Medicine

63

6 Comments

Exciting news! Pi Pharma Intelligence has been named as one of the MENA region's Top 10 Pioneers in Pharma Pre-Market Research. This huge achievement is all thanks to the tireless excellence of our team, who are constantly looking for opportunities to go above and beyond. Without them, Pi Pharma Intelligence would not be where it is today. I'd also like to thank Insights Success Global for giving me the chance to discuss our work in the latest edition of Insight Success Magazine. #PharmaInnovation #Gratitude #Top10Pioneers #PharmaInsights

39

20 Comments

RAS LifeScience Solutions is proud to sponsor the #GCCRegulatoryAffairsPharmaSummit and #MedicalTenderandBusinessTalk 2024 in #Dubai, focusing on #regulatoryaffairs and #tenderbusiness for the pharmaceutical industry in the #GCC region. We look forward to meeting and engaging with industry leaders and professionals. #GCCRegulatoryAffairsPharmaSummit #RegulatoryAffairs #MedicalTender #TenderBusiness #MTBT #BusinessDevelopment #Dubai #UAE #GCC #PharmaIndustry #Networking #MarketAccess #IndustryLeaders #Pharmaceuticals #Innovation #Consulting #MarketResearch #MarketIntelligence #CompetitiveIntelligence #RASLifescienceSolutions

2

If you are attending lets arrange to meet!! Connect using the app!! We can discuss Sustainability Scope 3.... Pharma or Biotech manufacturing. Sterility Assurance! How to implement criticality focussed manufacturing!!

2

In addition to the keynote at CPHI Middle East this week, our co-founder and CTO Thrasyvoulos Karydis will be on the panel “Exploring AI Potential in Pharma for Drug Discovery and Development" this Thursday, Dec 12. 🧬🧬 Moderated by Dean Calhoun, CIH, President/CEO of Affygility Solutions, with Thras and Majd Abdulghani, PhD, genomics lead at Lean Business Services and Saudi Arabia's first Rhodes Scholar. The panel will delve into the latest developments in AI-driven drug discovery and the impact of artificial intelligence on development timelines, & future possibilities for AI in pharmaceutical innovation collaborative opportunities in the Middle East's growing biotech sector. About CPHI Middle East 2024 CPHI Middle East 2024 will bring together over 400 exhibitors and 30,000 visitors from 100+ countries, focusing on pharmaceutical innovations, networking, and market opportunities in the Middle East. With more than 150 speakers and a backdrop of Saudi Arabia’s rapidly growing pharmaceutical market (projected to reach USD 12.1 billion), this gathering represents a significant opportunity for industry leaders to connect, learn, and drive forward pharmaceutical advancements in the region. More info here: 👇👇 https://lnkd.in/g67VB2fW

26

🎉 Exciting News! 🎉 We are thrilled to announce a groundbreaking partnership between Sargon, led by Dr. Amir Charaf, MD, and AKH-Consult: Analytics Knowledge Health, led by a team of experts. This collaboration unites two powerhouses in healthcare and pharmaceutical consulting. 🤝 Strategic Alliance This strategic alliance combines Sargon's 14+ years of international expertise in pricing, reimbursement, #marketaccess, medical and regulatory affairs with AKH-Consult: Analytics Knowledge Health's decade-long mastery in Health Economics and Outcomes Research (HEOR), clinical trials, and #CDISC #SDTM and #ADaM standards. 🌟 Comprehensive Services By joining forces, we're creating a comprehensive suite of services that spans the entire pharmaceutical value chain. Our combined strengths will enable us to offer unparalleled insights and solutions, helping clients navigate the complex landscape of drug development, market entry, and commercial success in Europe, Middle East, North Africa & Gulf Countries. 🚀 Innovation & Improvement This partnership represents a significant step forward in our commitment to driving innovation and improving patient outcomes in the healthcare and pharmaceutical sectors. 📧 Contact Us Get in touch with us at: Sargon: [email protected] AKH Consult: [email protected] 🌐 Visit Us Learn more by visiting our websites: • Sargon: sargon-group.com • AKH Consult: akh-consult.com #Partnership #JoinForces #MarketAccess #SDTM #ADaM

16

5 Comments

🌟 Excited to announce the upcoming ASMA | Annual Summit on Medical Affairs conference that Pfizer Div Khetia, PharmD, MBA are chairing where we'll delve into the latest trends shaping the future of medical affairs in the pharmaceutical industry! 💻 From embracing data and analytics to transforming medical leadership, the landscape is evolving at an unprecedented pace. 🏢 Join us as we explore the impact of #digitaltechnology and #collaborativepartnerships on the #strategicrole of #medicalaffairs. 🎇 Together, we'll navigate the nuances of talent development and the critical need for innovation in this dynamic space. 💡Don't miss this opportunity to gain insights and network with industry leaders at the forefront of redefining medical affairs in pharma, including the following: Carolyn Reever, Ph.D Varun Nagpal, PhD Dylan S.. Peter Gin-Fu Chen, PhD Veruska Sena Savita Nandal, MD Ami Bhatt, MD Bhaskar Dutta Arta Subagiarta, MD, MMSc Shashi Adsul Peter Covitz Stephanie Otis, PharmD CHC Dr Xongi Phaleng Tom Caravela Thomas Yang, PhD Vivek Mukhatyar Sandra Nagale, Ph.D. Hahn-Ey Lee MD, PhD, MBA Ann Westra Chippen Zhao Chathuri Daluwatte, PhD Roberto Araujo 🔗 Register here at https://lnkd.in/dEYgkzDJ! See you at the conference! #MedicalAffairs #PharmaceuticalIndustry #FutureTrends #ConferenceDiscussion 🚀

31

1 Comment

Highlighting Egypt's role in climate, equity, and resilience! 🇪🇬 At AstraZeneca, we’re reshaping patient journeys and partnering to boost health outcomes for many. Addressing climate change, transforming health systems, and enhancing health equity requires a 100% patient-focused mindset. In this #TheBelievers episode, Egypt sales manager Mohamed Khamis discusses the significant sustainability projects in the MEA region. This includes working with health systems on sustainable healthcare delivery and deploying mobile hospitals in rural communities. Be inspired by this short film! #Healthcare #Sustainability #ClimateAction

13

How Elixir Healthcare USA Supports Iraq’s Growing Healthcare Needs At Elixir Healthcare USA, we are dedicated to addressing Iraq’s healthcare challenges by collaborating with local importers, distributors, and healthcare providers. We supply high-quality pharmaceuticals and nutritional supplements to meet the needs of the Iraqi people. Meeting Iraq’s Healthcare Needs With a rise in chronic diseases, malnutrition, and infections, Iraq is facing an increased demand for essential healthcare products. At Elixir, we offer key products to address these needs: Chronic Disease Medications: Our range includes cardiovascular, diabetes, and respiratory medicines, vital for managing Iraq's chronic disease burden. Oncology Treatments: We provide chemotherapy agents and supportive care medications to address rising cancer cases. OTC Medications: Our pain relievers, cold remedies, and gastrointestinal treatments meet the daily healthcare needs of Iraqi families. Nutritional Supplements: We offer vitamins, minerals, and protein supplements to address nutritional deficiencies and promote well-being. Antibiotics and Antivirals: Our broad selection supports Iraq’s fight against infections. Veterinary Medicines: We provide veterinary products to support animal health and the agricultural sector. Supporting Our Local Partners At Elixir Healthcare USA, we focus on long-term partnerships with local distributors in Iraq. Here’s how we can support your business: Certified Products: Our products are manufactured in WHO-GMP, EU-GMP, and US FDA-certified facilities, ensuring the highest standards. Regulatory Assistance: We help local distributors navigate Iraq’s regulatory processes, including product registration and Ministry of Health compliance. Tailored Solutions: We offer products customized for the Iraqi market, including packaging and dosage suited to local needs. Reliable Supply Chain: Our global distribution network ensures timely delivery, maintaining a consistent supply chain in Iraq. Training and Support: We provide guidance on product handling, storage, and regulatory updates to support our partners’ success. Collaborative Expansion: We work with distributors to explore new opportunities and introduce innovative products to meet Iraq’s evolving healthcare needs. A Partnership for a Healthier Iraq At Elixir Healthcare USA, we believe in strong partnerships based on trust, quality, and shared goals. Together, we can improve access to essential healthcare products and contribute to the well-being of the Iraqi people. For more information, please reach out at [email protected]. Let's work together to meet Iraq’s growing healthcare needs.

1

1 Comment

At #evapharma we value the #family and we #belive in our #positive #impact on one another and in the #society so #sharing our #minds and #personalstories , #celebrating #occasions like #fathersday together is part of who we are and part of our #cutlure . #Happyfathersday2024

12

1 Comment

The environmental impact of pharmaceuticals beyond their intended use is indeed crucial for sustainable healthcare practices. Today I had the honor of defending my thesis on the topic “Ecopharmacovigilance future opportunities and challenges worldwide and in the Middle East” among experts Karine Palin, PhD Ahmed H. Maryam GHORAYEB Dr. Joan D’souza To discuss this emerging field. Emphasizing how ecopharmacovigilance aligns with global sustainability goals, showcasing its potential to contribute positively to both healthcare and environmental stewardship. Eu2P - European programme in Pharmacovigilance and Pharmacoepidemiology

62

28 Comments

🌟 Proud Moment for Localized Healthcare in Saudi Arabia! 🌟 I’m excited to share a significant step forward in advancing healthcare in the Kingdom. Sudair Pharmaceutical Company, in collaboration with Sanofi & National Unified Procurement Company "NUPCO" is making strides towards localizing #Insulin production in Saudi Arabia. This initiative isn’t just about meeting the growing demand for insulin in the region but about creating a robust, sustainable supply chain that caters to our unique healthcare landscape. By fostering local production, we aim to: • Ensure reliable access to life-saving insulin for patients across the Kingdom. • Reduce dependency on international supply chains. • Support national goals outlined in Saudi Vision 2030 to enhance self-sufficiency and localize essential industries. This collaboration is a testament to our shared commitment to empowering healthcare, uplifting our economy, and, most importantly, serving the people of Saudi Arabia. Stay tuned as we continue to make healthcare history together! 💪🌍 #Insulin #SaudiVision2030 #SudairPharma #Sanofi

318

10 Comments